H.C. Wainwright Reiterates Buy Rating on Gain Therapeutics (GANX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Oil slips but stays near six-month highs on Saudi attacks
| (NASDAQ: GANX) | Delayed: 1.26 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.26 | 52 Week High | $ | |||
| Open | $1.26 | 52 Week Low | $ | |||
| Day High | $1.26 | P/E | N/A | |||
| Day Low | $1.26 | EPS | $ | |||
| Volume | 20,161 | |||||
